Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ElectraTect is a biotechnology and diagnostics company focused on developing a portable breathalyzer for the detection of recent cannabis consumption. Spun out of UCLA, the company utilizes proprietary electrochemical sensor technology to identify Delta-9-tetrahydrocannabinol (THC) in human breath. Unlike traditional urine or blood tests that detect metabolites for days or weeks, ElectraTect's solution aims to provide a real-time assessment of impairment suitable for law enforcement and workplace safety. The company's mission is to provide a fair and accurate tool for distinguishing between past use and active intoxication. The core technology involves the electrochemical oxidation of THC, which generates a measurable signal proportional to the concentration in the sample.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ElectraTect.